Canadian Glycomics Network

GlycoNet GlycoNet is driving innovation in glycomics and its commercialization to improve human health and quality of life. The company focuses on developing new carbohydrate-based drugs, vaccines, and diagnostics, collaborating with academic and industry organizations to address unmet needs through applied glycomics research. Funded by the Networks of Centres of Excellence (NCE) program and a range of partners, the company includes over 170 researchers from Canada who are dedicated to cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.